Healthcare provider profile · identity verified

Randolph Marshall Baker, MD

Internal Medicine · PALMYRA, VA · NPI 1265448310

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	752	202
Amlodipine Besylate	Amlodipine Besylate	437	121
Lisinopril	Lisinopril	412	112
Losartan Potassium	Losartan Potassium	313	90
Omeprazole	Omeprazole	285	87
Levothyroxine Sodium	Levothyroxine Sodium	283	69
Metoprolol Succinate	Metoprolol Succinate	251	73
Rosuvastatin Calcium	Rosuvastatin Calcium	240	64
Metformin Hcl Er	Metformin Hcl	177	55
Trazodone Hcl	Trazodone Hcl	151	36
Albuterol Sulfate Hfa	Albuterol Sulfate	146	55
Eliquis	Apixaban	146	25
Gabapentin	Gabapentin	141	44
Jardiance	Empagliflozin	138	42
Tamsulosin Hcl	Tamsulosin Hcl	131	43
Hydrochlorothiazide	Hydrochlorothiazide	118	35
Tramadol Hcl	Tramadol Hcl	117	24
Spironolactone	Spironolactone	111	32
Allopurinol	Allopurinol	102	30
Ezetimibe	Ezetimibe	102	28
Pantoprazole Sodium	Pantoprazole Sodium	98	26
Olmesartan Medoxomil	Olmesartan Medoxomil	95	27
Sertraline Hcl	Sertraline Hcl	95	27
Duloxetine Hcl	Duloxetine Hcl	92	21
Furosemide	Furosemide	92	30
Metformin Hcl	Metformin Hcl	92	25
Simvastatin	Simvastatin	91	27
Montelukast Sodium	Montelukast Sodium	89	27
Famotidine	Famotidine	85	29
Carvedilol	Carvedilol	82	24
Zolpidem Tartrate	Zolpidem Tartrate	82	16
Fluticasone Propionate	Fluticasone Propionate	79	38
Clonazepam	Clonazepam	78	11
Pravastatin Sodium	Pravastatin Sodium	78	23
Farxiga	Dapagliflozin Propanediol	77	18
Meloxicam	Meloxicam	72	21
Bupropion Xl	Bupropion Hcl	67	21
Clopidogrel	Clopidogrel Bisulfate	67	17
Glimepiride	Glimepiride	67	20
Escitalopram Oxalate	Escitalopram Oxalate	62	12
Chlorthalidone	Chlorthalidone	57	17
Metoprolol Tartrate	Metoprolol Tartrate	56	19
Doxazosin Mesylate	Doxazosin Mesylate	55	17
Potassium Chloride	Potassium Chloride	55	21
Atenolol	Atenolol	52	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	50	suppressed
Synthroid	Levothyroxine Sodium	47	13
Fluoxetine Hcl	Fluoxetine Hcl	46	11
Alendronate Sodium	Alendronate Sodium	43	12
Pioglitazone Hcl	Pioglitazone Hcl	42	12
Mirtazapine	Mirtazapine	41	12
Tizanidine Hcl	Tizanidine Hcl	40	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	11
Topiramate	Topiramate	39	13
Finasteride	Finasteride	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	36	12
Diclofenac Sodium	Diclofenac Sodium	36	13
Prednisone	Prednisone	36	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	suppressed
Ropinirole Hcl	Ropinirole Hcl	35	12
Esomeprazole Magnesium	Esomeprazole Magnesium	33	suppressed
Torsemide	Torsemide	32	11
Alprazolam	Alprazolam	31	suppressed
Celecoxib	Celecoxib	31	12
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Ozempic	Semaglutide	30	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Lovastatin	Lovastatin	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	17
Donepezil Hcl	Donepezil Hcl	27	suppressed
Ibuprofen	Ibuprofen	27	suppressed
Lorazepam	Lorazepam	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	22
Valacyclovir	Valacyclovir Hcl	23	14
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	11
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Doxepin Hcl	Doxepin Hcl	20	suppressed
Felodipine Er	Felodipine	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Primidone	Primidone	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Azithromycin	Azithromycin	19	13
Diclofenac Sodium Er	Diclofenac Sodium	19	11
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Calcitriol	Calcitriol	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Loperamide	Loperamide Hcl	18	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	12
Estradiol	Estradiol	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Potassium Citrate Er	Potassium Citrate	17	suppressed
Amoxicillin	Amoxicillin	16	14
Ketoconazole	Ketoconazole	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	11
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Baclofen	Baclofen	15	suppressed
Glipizide	Glipizide	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	11
Valsartan	Valsartan	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Prempro	Estrogen,con/M-Progest Acet	13	suppressed
Ramipril	Ramipril	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Cephalexin	Cephalexin	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Temazepam	Temazepam	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error